Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...

US senior living bankruptcies increased during the pandemic, impacting Sonida Senior Living's equity stock. Click here to read my analysis of SNDA stock.

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine ...

sNDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved, FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare ...

Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising stocks according to Wall Street analysts. On June 24, ...

Travere submitted an sNDA to FDA for FILSPARI, potentially first treatment for FSGS, based on positive clinical trial results.

Such forward-looking statements include, but are not limited to, references to: statements regarding the FDA’s review of the Company’s sNDA for FILSPARI in FSGS, and expectations regarding the ...

The acknowledgment of the SNDA by the FDA is a procedural step, indicating that the submission has been officially received and will undergo a review process.

--Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a supplemental New ...

Attornment is the act of granting authority or jurisdiction to a party even though no legal rights exist.

Alnylam Pharmaceuticals Inc. ALNY said Monday it would no longer pursue its supplemental new drug application (sNDA) for patisiran as a treatment for the cardiomyopathy of transthyretin-mediated ...